| ABAT | GABA-transaminase deficiency | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✗ | 
        
      | ABCA12 | Ichthyosis | 16 | 0.00670017 | 0.0133106 | 0.000177171 | ✓ | 
        
      | ABCA4 | Retinal dystrophy | 53 | 0.0221943 | 0.0434034 | 0.00188386 | ✓ | 
        
      | ABCC6 | Pseudoxanthoma elasticum | 11 | 0.00460637 | 0.00917029 | 0.0000841 | ✓ | 
        
      | ABCC8 | Hyperinsulinism | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | ABCG8 | Sitosterolemia 1 | 10 | 0.0041876 | 0.00834014 | 0.0000696 | ✓ | 
        
      | ACAD8 | Isobutyryl-CoA dehydrogenase deficiency | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | ACADM | Acyl-CoA dehydrogenase | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | ACADS | Short-chain acyl-CoA-dehydrogenase deficiency | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
        
      | ACADSB | Inborn error of metabolism | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | ACADVL | Very long chain acyl-CoA dehydrogenase deficiency | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | ACO2 | Optic atrophy 9 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | ADA | Adenosine deaminase deficiency | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | ADA2 | Sneddon syndrome | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
        
      | ADAMTS13 | Reduced expression | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | ADAMTS17 | Weill-Marchesani syndrome | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | ADAMTS18 | Microcornea, myopic chorioretinal atrophy and telecanthus | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | ADGRV1 | Deafness, non-syndromic, autosomal recessive | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | AGK | Sengers syndrome | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
        
      | AGL | Glycogen storage disease 3 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | AGRN | Congenital myasthenic syndrome with distal muscle weakness & atrophy | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | AGXT | Hyperoxaluria | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
        
      | AHI1 | Joubert syndrome | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | AIPL1 | Leber congenital amaurosis IV | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | AIRE | Autoimmune polyendocrinopathy syndrome | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | AKR1D1 | Bile acid synthesis defect | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | ALDH3A2 | Sjogren-Larsson syndrome | 15 | 0.00628141 | 0.0124839 | 0.000155848 | ✓ | 
        
      | ALDH7A1 | Epilepsy | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | ALDOB | Fructose intolerance | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
        
      | ALG1 | Congenital disorder of glycosylation | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | ALG2 | Congenital disorder of glycosylation 1i | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | ALG3 | Congenital disorder of glycosylation | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | ALG8 | Congenital disorder of glycosylation 1h | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | ALMS1 | Alstrom syndrome | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
        
      | ALPL | Odontohypophosphatasia | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
        
      | ANO10 | Cerebellar ataxia 3 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | ANO5 | Muscular dystrophy, limb girdle 2L | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
        
      | ANTXR2 | Hyaline fibromatosis syndrome | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | AP4S1 | Spastic paraplegia 52 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | APTX | Ataxia | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | ARSA | Metachromatic leukodystrophy | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | ARSB | Mucopolysaccharidosis type VI (Maroteaux-Lamy) | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | ASAH1 | Spinal muscular atrophy with progressive myoclonic epilepsy | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | ASL | Argininosuccinic aciduria | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | ASPM | Microcephaly 5 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | ATM | Ataxia-telangiectasia | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
        
      | ATP13A2 | Kufor-Rakeb syndrome | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | ATP2A1 | Autism spectrum disorder | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
        
      | ATP7B | Wilson disease | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
        
      | ATP9A | Neurodevelopmental disorder with poor growth and behavioral abnormalities | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | ATR | Pulmonary fibrosis / aplastic anaemia | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | AVIL | Nephrotic syndrome | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
        
      | B3GALNT2 | Muscular dystrophy-dystroglycanopathy | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | B3GALT6 | Spondyloepimetaphyseal dysplasia with joint laxity | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | B3GAT3 | Multiple joint dislocations | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
        
      | B3GLCT | Peters-Plus syndrome | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | B4GALNT1 | Spastic paraplegia | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | BBS5 | Phenotype modifier | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | BBS7 | Bardet-Biedl syndrome, modifier of | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | BBS9 | Retinitis pigmentosa | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | BCHE | Butyrylcholinesterase deficiency | 29 | 0.0121441 | 0.0239932 | 0.000575671 | ✓ | 
        
      | BCS1L | GRACILE syndrome | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | BLM | Breast cancer | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | BTD | Biotinidase deficiency | 17 | 0.00711893 | 0.0141365 | 0.000199841 | ✓ | 
        
      | C2CD3 | Autism spectrum disorder | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | C5 | Complement C5 deficiency | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | C6 | Inflammatory bowel disease, very early onset | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
        
      | C7 | Alzheimer disease in Han Chinese, association with | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
        
      | C8A | Complement C8 alpha-gamma deficiency | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
        
      | C8B | Primary immunodeficiency disease | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | CA5A | Carbonic anhydrase VA deficiency | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
        
      | CABP4 | Retinal dystrophy | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | CAPN3 | Muscular dystrophy, limb girdle 2A | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
        
      | CBS | Homocystinuria | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | CCDC103 | Primary ciliary dyskinesia | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | CCDC39 | Primary ciliary dyskinesia | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | CCDC40 | Primary ciliary dyskinesia | 8 | 0.00335008 | 0.00667772 | 0.0000446 | ✓ | 
        
      | CCN6 | Pseudorheumatoid dysplasia, progressive | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | CCNO | Ciliary dyskinesia | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
        
      | CD36 | Platelet glycoprotein IV deficiency | 41 | 0.0171692 | 0.0337488 | 0.00113898 | ✓ | 
        
      | CDH23 | Usher syndrome | 11 | 0.00460637 | 0.00917029 | 0.0000841 | ✓ | 
        
      | CDH3 | Hypotrichosis | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | CDK5RAP2 | Autism spectrum disorder | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
        
      | CENPJ | Intellectual disability | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | CEP152 | Seckel syndrome | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | CEP290 | Leber congenital amaurosis 10 | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
        
      | CERS3 | Ichthyosis | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | CFAP410 | Retinitis pigmentosa | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | CFAP53 | Dextrocardia and situs disturbances | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | CFTR | Cystic fibrosis | 8 | 0.00335008 | 0.00667772 | 0.0000446 | ✓ | 
        
      | CHRNE | Congenital myasthenic syndrome | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | CHRNG | Multiple pterygium syndrome | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | CLCNKB | Bartter syndrome | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | CLMP | Congenital short-bowel syndrome | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | CLN3 | Retinal dystrophy, early-onset | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | CNGA3 | Achromatopsia 2 | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
        
      | CNGB3 | Achromatopsia 3 | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
        
      | CNTN2 | Hypogonadotropic hypogonadism | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | CNTNAP1 | Hypomyelinating neuropathy | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | COG7 | Schizophrenia | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | COL17A1 | Epithelial recurrent erosion dystrophy | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
        
      | COL18A1 | Knobloch syndrome | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | COL27A1 | Steel syndrome | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | COL6A2 | Bethlem myopathy 1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | COL7A1 | EBD | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | COQ9 | Primary coenzyme Q10 deficiency, neonatal onset | 8 | 0.00335008 | 0.00667772 | 0.0000446 | ✓ | 
        
      | CORO1A | Haemophagocytic lymphohistiocytosis | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | COX15 | Hypertrophic cardiomyopathy, early onset | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | COX20 | Dysarthria, ataxia and sensory neuropathy | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | CPLANE1 | Joubert syndrome | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
        
      | CRB1 | Leber congenital amaurosis 8 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | CRB2 | Congenital nephrosis, Finnish type-like, with cerebral ventriculomegaly & raised alpha-fetoprotein | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | CRIPT | Short stature, microcephaly & dysmorphic facies | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | CTNS | Cystinosis | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | CTSK | Pycnodysostosis | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | CUBN | Albuminuria, association with | 52 | 0.0217755 | 0.0426027 | 0.00181499 | ✓ | 
        
      | CUL7 | 3-M syndrome 1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | CYP11B1 | Steroid-11 beta-hydroxylase deficiency | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
        
      | CYP1B1 | Glaucoma 3A | 27 | 0.0113065 | 0.0223574 | 0.000499853 | ✓ | 
        
      | CYP21A2 | Hyperandrogenism | 135 | 0.0565327 | 0.106673 | 0.0113792 | ✓ | 
        
      | CYP27A1 | Cerebrotendinous xanthomatosis | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | CYP4V2 | Retinitis pigmentosa | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | DARS2 | Leukoencephalopathy with brainstem & spinal cord involvement | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | DGAT1 | Diarrhea | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | DGUOK | Portal hypertension | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | DHODH | Miller syndrome | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | DLL3 | Congenital scoliosis | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | DNAAF1 | Neural tube defects | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | DNAH11 | Ciliary dyskinesia | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | DNAH5 | Primary ciliary dyskinesia | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
        
      | DNAH9 | Situs inversus and male infertility | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | DNASE1L3 | Systemic lupus erythematosus 16 | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
        
      | DOCK6 | Adams-Oliver syndrome 2 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | DOCK8 | Immunodeficiency, primary | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | DOK7 | Fetal akinesia deformation sequence 3 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | DONSON | Microcephaly | 23 | 0.00963149 | 0.0190775 | 0.000363949 | ✓ | 
        
      | DPAGT1 | Congenital disorder of glycosylation 1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | DPYD | Dihydropyrimidine dehydrogenase deficiency | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
        
      | DPYS | Dihydropyrimidinase deficiency | 8 | 0.00335008 | 0.00667772 | 0.0000446 | ✓ | 
        
      | DSP | Cardiomyopathy, arrhythmogenic right ventricular | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | DUOX2 | Hypothyroidism | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
        
      | DYNC2H1 | Asphyxiating thoracic dystrophy | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
        
      | DYNC2I1 | Short-rib thoracic dysplasia 8 with or without polydactyly | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | ECEL1 | Arthrogryposis | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | ECHS1 | Short-chain enoyl-CoA hydratase deficiency | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | EDARADD | Ectodermal dysplasia 11A | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | ELP1 | Autism spectrum disorder | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | EPG5 | Vici syndrome | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | ERCC2 | Basal cell carcinoma, reduced risk, association with | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | ESPN | Hearing loss | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | EVC2 | Ellis-van Creveld syndrome | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | EXOSC3 | Pontocerebellar hypoplasia 1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | EXPH5 | Epidermolysis bullosa, junctional | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | EYS | Retinitis pigmentosa | 15 | 0.00628141 | 0.0124839 | 0.000155848 | ✓ | 
        
      | F11 | Factor XI deficiency | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
        
      | F2 | Thrombophilia 1 due to thrombin defect | 22 | 0.00921273 | 0.0182557 | 0.000333271 | ✓ | 
        
      | F7 | Factor VII deficiency | 18 | 0.00753769 | 0.0149617 | 0.000223854 | ✓ | 
        
      | FA2H | Spastic paraplegia 35 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | FAH | Tyrosinemia | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
        
      | FAM161A | Retinitis pigmentosa | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | FANCC | Fanconi anemia | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | FBP1 | Fructose-1,6-bisphosphatase deficiency | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | FBXO7 | Parkinsonism, juvenile | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | FH | Multiple leiomyomatosis | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | FIG4 | Amyotrophic lateral sclerosis, sporadic | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | FLVCR1 | Posterior column ataxia & retinitis pigmentosa | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | FOXRED1 | Complex I deficiency | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | FRAS1 | Congenital anomalies of the kidney and urinary tract | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | FRRS1L | Intellectual disability, developmental delay & seizures | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | FTCD | Formiminoglutamic acidura | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | G6PC1 | Glycogen storage disease Ia | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | GAA | Glycogen storage disease II | 10 | 0.0041876 | 0.00834014 | 0.0000696 | ✓ | 
        
      | GALC | Krabbe disease | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
        
      | GALK1 | Galactokinase deficiency, presenile cataract | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | GALNS | Mucopolysaccharidosis IVA | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | GALNT3 | Tumoral calcinosis | 16 | 0.00670017 | 0.0133106 | 0.000177171 | ✓ | 
        
      | GAMT | Cerebral creatine deficiency syndrome 2 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | GBA | Gaucher disease | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
        
      | GBA2 | Spastic paraplegia | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | GBE1 | Glycogen storage disease 4 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | GCDH | Glutaric acidaemia 1 | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
        
      | GDAP1 | Charcot-Marie-Tooth disease | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | GFPT1 | Congenital myasthenic syndrome | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | GHR | Hypogonadotropic hypogonadism | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | GIPC3 | Hearing loss, non-syndromic | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | GJB2 | Keratoderma | 30 | 0.0125628 | 0.02481 | 0.000615535 | ✓ | 
        
      | GLB1 | GM1-gangliosidosis | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | GLDC | Glycine encephalopathy | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
        
      | GNE | GNE myopathy | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
        
      | GNPTAB | Mucolipidosis III alpha/beta | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | GNRHR | Hypogonadotropic hypogonadism | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
        
      | GP6 | Absence of collagen-induced platelet activation | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
        
      | GPHN | Hyperekplexia | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | GPR179 | Autism spectrum disorder | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | GRHPR | Hyperoxaluria II | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | GRM6 | Congenital stationary night blindness | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
        
      | GYS2 | Glycogen storage disease 0 | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
        
      | HADHB | Mitochondrial trifunctional protein deficiency | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | HBA1 | Haemoglobin variant | 34 | 0.0142379 | 0.0280703 | 0.000787941 | ✓ | 
        
      | HBA2 | Haemoglobin variant | 22 | 0.00921273 | 0.0182557 | 0.000333271 | ✓ | 
        
      | HBB | Haemoglobin variant | 121 | 0.05067 | 0.0962051 | 0.00925543 | ✓ | 
        
      | HBD | Haemoglobin variant | 31 | 0.0129816 | 0.0256261 | 0.000656697 | ✓ | 
        
      | HEXA | [Hex A pseudodeficiency] | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | HGD | Alkaptonuria | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | HGSNAT | Mucopolysaccharidosis type IIIC (Sanfilippo C) | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | HPS3 | Hermansky-Pudlak syndrome 3 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | HSD11B2 | Apparent mineralocorticoid excess | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | HSD17B3 | Pseudohermaphroditism, male | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | HSD17B4 | D-bifunctional protein deficiency | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | HSPG2 | Scoliosis, idiopathic, association with | 14 | 0.00586265 | 0.0116566 | 0.000135875 | ✓ | 
        
      | IDUA | Hurler syndrome | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | IFT140 | Leber congenital amaurosis | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | IL12RB1 | Mycobacterial infection | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | IL17RA | IL-17RA deficiency with bacterial and fungal infections | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
        
      | INPP5E | Joubert syndrome 1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | IQCB1 | Leber congenital amaurosis | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | ITGB2 | Leukocyte adhesion deficiency | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | ITGB3 | Bleeding disorder | 15 | 0.00628141 | 0.0124839 | 0.000155848 | ✓ | 
        
      | ITGB4 | Hirschsprung disease | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | IVD | Isovaleric acidemia | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | IYD | Hypothyroidism | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | JAK3 | Immunodeficiency, severe combined | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | KCNJ1 | Bartter syndrome | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
        
      | KCNV2 | Retinal cone dystrophy 3B | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | KIAA0586 | Joubert syndrome | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | KIF1C | Cerebellar ataxia | 10 | 0.0041876 | 0.00834014 | 0.0000696 | ✓ | 
        
      | KIF7 | Macrocephaly, multiple epiphyseal dysplasia & facial features | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | KLHL7 | Retinitis pigmentosa 42 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | LAMA1 | Schizophrenia | 9 | 0.00376884 | 0.00750928 | 0.0000564 | ✓ | 
        
      | LAMA3 | Epidermolysis bullosa, junctional | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | LAMB2 | Pierson syndrome/ nephrotic syndrome type 5 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | LAMC2 | Epidermolysis bullosa, Herlitz | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | LDLR | LDL cholesterol level QTL2 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | LHX3 | Hypopituitarism and sensorineural hearing loss | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | LIFR | Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | LIG4 | Marfan syndrome, early-onset | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | LINS1 | Intellectual developmental disorder | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | LMAN1 | Factor V and factor VIII deficiency, combined | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | LMBR1 | Triphalangeal thumbs and preaxial polydactyly | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | LMNA | Mandibuloacral dysplasia | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | LOXHD1 | Deafness | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
        
      | LOXL3 | Myopia 28 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | LPL | Hyperlipidaemia | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | LRPPRC | Infantile mitochondrial disease, lethal | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | LRRK1 | Osteosclerotic metaphyseal dysplasia | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | LYST | Chediak-Higashi syndrome | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | MALT1 | Immunodeficiency, combined | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | MAPKBP1 | Nephronophthisis, late onset | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | MCIDAS | Ciliary dyskinesia | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | MEFV | Neutrophilic dermatosis | 73 | 0.0305695 | 0.05927 | 0.00351294 | ✓ | 
        
      | MKS1 | Parkinson disease, early onset | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | MMACHC | Methylmalonic aciduria and homocystinuria | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | MMADHC | Homocystinuria, cblD type | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | MMUT | Methylmalonic aciduria | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | MOCOS | Thiopurine-induced toxicity | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | MPL | Thrombocytosis, association with | 9 | 0.00376884 | 0.00750928 | 0.0000564 | ✓ | 
        
      | MPLKIP | Trichothiodystrophy, nonphotosensitive | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | MPV17 | Mitochondrial DNA depletion syndrome, hepatocerebral | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | MRE11 | Breast cancer | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | MTRR | Cleft lip with or without cleft palate | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | MVK | Hyper-IgD syndrome | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
        
      | MYO15A | Deafness, non-syndromic, autosomal recessive | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | MYO5B | Diarrhea 2 | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
        
      | NBAS | Bone, connective tissue, liver, immune system & retinal defects | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | NBN | Breast cancer, male | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | NCF1 | Chronic granulomatous disease | 8 | 0.00335008 | 0.00667772 | 0.0000446 | ✓ | 
        
      | NCF2 | Chronic granulomatous disease | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | NDUFAF5 | Leigh syndrome/Mitochondrial Complex I deficiency | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | NDUFS1 | Neurodevelopmental disorder | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | NEK1 | Amyotrophic lateral sclerosis | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | NEK8 | Renal disease with hepatic and cardiac anomalies | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | NKX6-2 | Spastic ataxia 8 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | NPHP1 | Nephronophthisis 1 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | NPHP4 | Nephronophthisis 4 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | NPHS1 | Nephrotic syndrome | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | NR2E3 | Retinitis pigmentosa 37 | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
        
      | NUBPL | Complex I deficiency | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | OBSL1 | Cardiomyopathy, dilated | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
        
      | OCLN | Pseudo-TORCH syndrome 1 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | OPA1 | Optic atrophy plus syndrome | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | ORC4 | Lymphoproliferative disorder | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | ORC6 | Meier-Gorlin syndrome | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
        
      | OTOA | Hearing loss | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | OTOF | Deafness, non-syndromic | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | OTOG | Hearing loss, sensorineural | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | OTOGL | Hearing impairment | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
        
      | PAH | Hyperphenylalaninemia | 40 | 0.0167504 | 0.0329397 | 0.00108502 | ✓ | 
        
      | PANK2 | Neurodegeneration with brain iron accumulation 1 | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
        
      | PC | Hyperinsulinism | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | PCARE | Retinitis pigmentosa 54 | 8 | 0.00335008 | 0.00667772 | 0.0000446 | ✓ | 
        
      | PCCB | Propionicacidemia | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | PCDH15 | Usher syndrome 1 | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
        
      | PDE6B | Retinitis pigmentosa, pericentral | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | PDP1 | Tourette syndrome | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | PEPD | Prolidase deficiency | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | PEX1 | Zellweger syndrome | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | PEX12 | Peroxisome biogenesis disorder 3B | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | PEX16 | Peroxisome biogenesis disorder 8B | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | PEX26 | Refsum disease, infantile | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | PEX6 | Peroxisome biogenesis disorder 4B | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | PGM1 | Congenital disorder of glycosylation | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | PGM3 | Fetal alcohol syndrome, predisposition to | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | PHC1 | Primary microcephaly | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | PHGDH | Neu-Laxova syndrome 1 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | PIGO | PIGO deficiency | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
        
      | PJVK | Deafness | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
        
      | PKHD1 | Polycystic kidney disease 4 | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
        
      | PKLR | Pyruvate kinase deficiency | 18 | 0.00753769 | 0.0149617 | 0.000223854 | ✓ | 
        
      | PLA2G6 | Infantile neuroaxonal dystrophy | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | PLEKHG5 | Myopathy | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | PLOD1 | Ehlers-Danlos syndrome | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
        
      | PMM2 | Congenital disorder of glycosylation 1a | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | PNP | Nucleoside phosphorylase deficiency | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | PNPO | Pyridoxamine 5'-phosphate oxidase deficiency | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | POLG | Mitochondrial recessive ataxia syndrome | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | POR | Altered function | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | PRG4 | Camptodactyly-arthropathy-coxa vara-pericarditis syndrome | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
        
      | PRICKLE1 | Neural tube defects | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | PROC | Thrombophilia 3 due to protein C deficiency | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | PRUNE1 | Hypotonia, microcephaly and global developmental delay | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | PSAP | Combined SAP deficiency | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
        
      | PSAT1 | Developmental disorder | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | PTPRQ | Congenital sensorineural hearing loss, autosomal recessive | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
        
      | PTS | Tetrahydrobiopterin deficiency | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | PYGL | Glycogen storage disease 6 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | PYGM | McArdle disease | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | QARS1 | Microcephaly | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | QDPR | Dihydropteridine reductase deficiency | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | RAB3GAP2 | Microphthalmia & cataract | 10 | 0.0041876 | 0.00834014 | 0.0000696 | ✓ | 
        
      | RAG1 | Omenn syndrome | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | RAPSN | Congenital myasthenic syndrome | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | RARS2 | Pulmonary arterial hypertension | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
        
      | RAX | Microphthalmia | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | RECQL4 | Baller-Gerold syndrome | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | RFXANK | MHC class II deficiency | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | RNASEH2A | Aicardi-Goutieres syndrome 4 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | RNASEH2B | Aicardi-Goutières syndrome | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | RNASEH2C | Aicardi-Goutieres syndrome 3 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | ROBO3 | Gaze palsy | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | ROGDI | Kohlschütter-Tönz syndrome | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | RPGRIP1 | Cone-rod dystrophy 13 | 11 | 0.00460637 | 0.00917029 | 0.0000841 | ✓ | 
        
      | RTTN | Primary microcephaly & primordial dwarfism | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | RYR1 | Congenital myopathy 1B | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | SACS | Spastic ataxia, Charlevoix-Saguenay | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | SAG | Retinitis pigmentosa, autosomal recessive | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | SBDS | Shwachman-Diamond syndrome | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
        
      | SBF1 | Charcot-Marie-Tooth disease | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | SCN4A | Paramyotonia congenita | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | SCN9A | Childhood absence epilepsy | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | SEC23B | Anaemia, dyserythropoietic congenital, type II | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | SEPSECS | Cerebellar atrophy | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | SERPINA1 | Reduced alpha-1-antitrypsin concentration | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | SERPINF1 | Osteogenesis imperfecta | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | SGCD | Muscular dystrophy | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | SGCG | Muscular dystrophy, limb girdle | 32 | 0.0134003 | 0.0264415 | 0.000699155 | ✓ | 
        
      | SGSH | Mucopolysaccharidosis type IIIA (Sanfilippo A) | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | SI | Sucrase isomaltase deficiency | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
        
      | SKIV2L | Macular degeneration, age related, reduced risk | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | SLC12A3 | Gitelman syndrome | 8 | 0.00335008 | 0.00667772 | 0.0000446 | ✓ | 
        
      | SLC19A3 | Wernicke's-like encephalopathy | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | SLC22A5 | Carnitine deficiency | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | SLC25A13 | Intrahepatic cholestasis, neonatal | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | SLC25A19 | Thiamine metabolism dysfunction syndrome 4 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | SLC25A20 | Carnitine-acylcarnitine translocase deficiency | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | SLC26A4 | Deafness | 19 | 0.00795645 | 0.0157863 | 0.000249207 | ✓ | 
        
      | SLC2A1 | Glucose transporter type 1 deficiency syndrome | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | SLC34A1 | ?Fanconi renotubular syndrome 2 | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | SLC35D1 | Schneckenbecken dysplasia | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | SLC37A4 | Glycogen storage disease 1b | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | SLC38A8 | Foveal hypoplasia, optic nerve decussation defects and anterior segment dysgenesis | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | SLC39A14 | ?Hyperostosis cranalis interna | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | SLC3A1 | Cystinuria | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
        
      | SLC5A7 | Neuronopathy | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | SLC6A19 | Hartnup disorder | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | SMPD1 | Niemann-Pick disease | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | SORD | Neuronopathy, distal hereditary motor, autosomal recessive 8 | 12 | 0.00502513 | 0.00999975 | 0.0001 | ✓ | 
        
      | SPATA7 | Leber congenital amaurosis 3 | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | SPG11 | Charcot-Marie-Tooth disease | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
        
      | SPG7 | Spastic paraplegia | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
        
      | SPTA1 | Spherocytosis | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
        
      | STRC | Deafness, non-syndromic | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | SVBP | Neurodevelopmental disorder with ataxia | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | TGM1 | Ichthyosiform erythroderma, congenital, nonbullous | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | THOC6 | Intellectual disability | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | TMC1 | Deafness | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | TMCO1 | Cerebro-facio-thoracic dysplasia | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | TMEM107 | Oral-facial-digital syndrome | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | TMEM138 | Joubert syndrome 16 | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
        
      | TMEM231 | Meckel syndrome | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | TMEM237 | Joubert syndrome related disorder | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | TMEM67 | Nephronophthisis 11 | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
        
      | TMPRSS3 | Hearing loss | 4 | 0.00167504 | 0.00334447 | 0.0000112 | ✓ | 
        
      | TPI1 | Hemolytic anemia due to triosephosphate isomerase deficiency | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | TPO | Thyroid dyshormonogenesis 2A | 15 | 0.00628141 | 0.0124839 | 0.000155848 | ✓ | 
        
      | TPRN | Hearing loss | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
        
      | TRAPPC9 | Hypogonadotropic hypogonadism, normosmic | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | TRIOBP | Developmental disorder | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
        
      | TRIP4 | Spinal muscular atrophy & congenital bone fractures | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
        
      | TRMT10A | Neurodevelopmental disorder | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | TRPM1 | Night blindness | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | TSEN54 | Intellectual disability & epilepsy | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | TTC21B | Bardet-Biedl syndrome | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ | 
        
      | TTC37 | Fatigue, failure to thrive & diarrhoea | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
        
      | TTC7A | Immunodeficiency, combined, with intestinal atresias | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | TTN | Muscular dystrophy | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | TUBGCP6 | Diaphragmatic hernia | 3 | 0.00125628 | 0.00250941 | 0.0000063 | ✓ | 
        
      | TYR | Albinism, oculocutaneous | 14 | 0.00586265 | 0.0116566 | 0.000135875 | ✓ | 
        
      | UBR1 | Johanson-Blizzard syndrome | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | UFSP2 | ?Hip dysplasia | 7 | 0.00293132 | 0.00584546 | 0.0000342 | ✓ | 
        
      | UPB1 | Beta-ureidopropionase deficiency | 10 | 0.0041876 | 0.00834014 | 0.0000696 | ✓ | 
        
      | USH2A | Retinitis Pigmentosa | 13 | 0.00544389 | 0.0108285 | 0.000117256 | ✓ | 
        
      | VARS2 | Mitochondrial encephalopathy | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | VDR | Rickets | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
        
      | VPS13B | Cohen syndrome | 5 | 0.0020938 | 0.00417884 | 0.0000175 | ✓ | 
        
      | VPS33B | Arthrogryposis, renal dysfunction and cholestasis | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | VPS53 | Parkinson disease, early onset | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | VWF | von Willebrand disease | 9 | 0.00376884 | 0.00750928 | 0.0000564 | ✓ | 
        
      | WDR35 | Short rib-polydactyly syndrome | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | WDR62 | Microcephaly, primary | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | WHRN | Usher syndrome | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | WRN | Werner syndrome | 2 | 0.000837521 | 0.00167364 | 0.0000028 | ✓ | 
        
      | XPNPEP3 | NPHP-like kidney disease | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | XYLT1 | Desbuquois dysplasia 2 | 1 | 0.00041876 | 0.00083717 | 0.000000701 | ✓ | 
        
      | ZFYVE26 | Spastic paraplegia with thin corpus callosum | 6 | 0.00251256 | 0.0050125 | 0.0000251 | ✓ |